Financial results - BIOTECHNOLOGY CONSULTING SRL

Financial Summary - Biotechnology Consulting Srl
Unique identification code: 34483597
Registration number: J01/375/2015
Nace: 7490
Sales - Ron
4.724
Net Profit - Ron
-394
Employees
Open Account
Company Biotechnology Consulting Srl with Fiscal Code 34483597 recorded a turnover of 2024 of 4.724, with a net profit of -394 and having an average number of employees of - . The company operates in the field of Alte activitati profesionale, stiintifice si tehnice n.c.a. having the NACE code 7490.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Biotechnology Consulting Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.256 1.338 2.747 0 10.737 3.763 5.408 21.211 2.001 4.724
Total Income - EUR 1.256 1.338 2.747 0 10.737 4.039 5.684 21.467 2.257 4.979
Total Expenses - EUR 1.140 1.331 1.376 590 1.420 2.326 4.221 5.673 2.855 5.264
Gross Profit/Loss - EUR 116 7 1.372 -590 9.317 1.712 1.463 15.795 -598 -285
Net Profit/Loss - EUR 89 6 1.289 -590 8.995 1.603 1.301 15.171 -598 -394
Employees 0 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 137.4%, from 2.001 euro in the year 2023, to 4.724 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Biotechnology Consulting Srl

Rating financiar

Financial Rating -
BIOTECHNOLOGY CONSULTING SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Biotechnology Consulting Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biotechnology Consulting Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Biotechnology Consulting Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biotechnology Consulting Srl - CUI 34483597

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 122 121 119 117 114 1.755 1.464 1.203 935 666
Current Assets 412 507 1.524 953 10.424 3.518 5.613 18.250 9.644 10.165
Inventories 0 22 50 125 122 209 1.476 1.591 1.773 1.763
Receivables 337 0 219 215 10.210 507 718 14.526 3.806 3.968
Cash 74 485 1.255 614 92 2.803 3.419 2.133 4.065 4.433
Shareholders Funds 134 138 1.425 808 9.788 1.695 2.958 15.212 7.686 7.249
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 400 490 218 262 751 1.577 2.396 2.771 1.683 2.633
Income in Advance 0 0 0 0 0 2.001 1.722 1.470 1.210 948
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7490 - 7490"
CAEN Financial Year 7490
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 10.165 euro in 2024 which includes Inventories of 1.763 euro, Receivables of 3.968 euro and cash availability of 4.433 euro.
The company's Equity was valued at 7.249 euro, while total Liabilities amounted to 2.633 euro. Equity decreased by -394 euro, from 7.686 euro in 2023, to 7.249 in 2024. The Debt Ratio was 24.3% in the year 2024.

Risk Reports Prices

Reviews - Biotechnology Consulting Srl

Comments - Biotechnology Consulting Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.